Logo image of NVRI

ENVIRI CORP (NVRI) Stock Fundamental Analysis

USA - NYSE:NVRI - US4158641070 - Common Stock

12.35 USD
-0.06 (-0.48%)
Last: 10/17/2025, 8:04:01 PM
12.35 USD
0 (0%)
After Hours: 10/17/2025, 8:04:01 PM
Fundamental Rating

2

Overall NVRI gets a fundamental rating of 2 out of 10. We evaluated NVRI against 82 industry peers in the Commercial Services & Supplies industry. NVRI has a bad profitability rating. Also its financial health evaluation is rather negative. NVRI has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year NVRI has reported negative net income.
In the past year NVRI had a positive cash flow from operations.
NVRI had negative earnings in each of the past 5 years.
Each year in the past 5 years NVRI had a positive operating cash flow.
NVRI Yearly Net Income VS EBIT VS OCF VS FCFNVRI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M

1.2 Ratios

Looking at the Return On Assets, with a value of -5.68%, NVRI is doing worse than 68.29% of the companies in the same industry.
Looking at the Return On Equity, with a value of -41.84%, NVRI is doing worse than 74.39% of the companies in the same industry.
NVRI has a Return On Invested Capital (1.53%) which is comparable to the rest of the industry.
NVRI had an Average Return On Invested Capital over the past 3 years of 2.87%. This is significantly below the industry average of 10.38%.
Industry RankSector Rank
ROA -5.68%
ROE -41.84%
ROIC 1.53%
ROA(3y)-4.77%
ROA(5y)-3.06%
ROE(3y)-26.4%
ROE(5y)-16.72%
ROIC(3y)2.87%
ROIC(5y)2.63%
NVRI Yearly ROA, ROE, ROICNVRI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

1.3 Margins

With a Operating Margin value of 1.86%, NVRI perfoms like the industry average, outperforming 41.46% of the companies in the same industry.
NVRI's Operating Margin has declined in the last couple of years.
Looking at the Gross Margin, with a value of 18.36%, NVRI is doing worse than 78.05% of the companies in the same industry.
NVRI's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 1.86%
PM (TTM) N/A
GM 18.36%
OM growth 3Y-11.02%
OM growth 5Y-12.23%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1%
GM growth 5Y-3.78%
NVRI Yearly Profit, Operating, Gross MarginsNVRI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40

1

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), NVRI is destroying value.
NVRI has more shares outstanding than it did 1 year ago.
The number of shares outstanding for NVRI has been increased compared to 5 years ago.
The debt/assets ratio for NVRI is higher compared to a year ago.
NVRI Yearly Shares OutstandingNVRI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
NVRI Yearly Total Debt VS Total AssetsNVRI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

NVRI has an Altman-Z score of 1.84. This is not the best score and indicates that NVRI is in the grey zone with still only limited risk for bankruptcy at the moment.
The Altman-Z score of NVRI (1.84) is comparable to the rest of the industry.
NVRI has a Debt/Equity ratio of 3.97. This is a high value indicating a heavy dependency on external financing.
NVRI has a Debt to Equity ratio of 3.97. This is amonst the worse of the industry: NVRI underperforms 82.93% of its industry peers.
Industry RankSector Rank
Debt/Equity 3.97
Debt/FCF N/A
Altman-Z 1.84
ROIC/WACC0.18
WACC8.69%
NVRI Yearly LT Debt VS Equity VS FCFNVRI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B

2.3 Liquidity

NVRI has a Current Ratio of 1.19. This is a normal value and indicates that NVRI is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.19, NVRI is not doing good in the industry: 67.07% of the companies in the same industry are doing better.
A Quick Ratio of 0.88 indicates that NVRI may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.88, NVRI is doing worse than 73.17% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.19
Quick Ratio 0.88
NVRI Yearly Current Assets VS Current LiabilitesNVRI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

3

3. Growth

3.1 Past

NVRI shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -1400.00%.
NVRI shows a decrease in Revenue. In the last year, the revenue decreased by -0.92%.
The Revenue has been growing by 14.23% on average over the past years. This is quite good.
EPS 1Y (TTM)-1400%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1200%
Revenue 1Y (TTM)-0.92%
Revenue growth 3Y8.22%
Revenue growth 5Y14.23%
Sales Q2Q%-7.83%

3.2 Future

Based on estimates for the next years, NVRI will show a very strong growth in Earnings Per Share. The EPS will grow by 85.86% on average per year.
NVRI is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.49% yearly.
EPS Next Y-608.34%
EPS Next 2Y63.71%
EPS Next 3Y85.86%
EPS Next 5YN/A
Revenue Next Year-4.15%
Revenue Next 2Y-0.29%
Revenue Next 3Y0.92%
Revenue Next 5Y2.49%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
NVRI Yearly Revenue VS EstimatesNVRI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 1B 2B 3B
NVRI Yearly EPS VS EstimatesNVRI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.5 1

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for NVRI. In the last year negative earnings were reported.
The Price/Forward Earnings ratio is 302.70, which means the current valuation is very expensive for NVRI.
The rest of the industry has a similar Price/Forward Earnings ratio as NVRI.
When comparing the Price/Forward Earnings ratio of NVRI to the average of the S&P500 Index (22.94), we can say NVRI is valued expensively.
Industry RankSector Rank
PE N/A
Fwd PE 302.7
NVRI Price Earnings VS Forward Price EarningsNVRI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 100 200 300

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, NVRI is valued a bit cheaper than 63.41% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 10.9
NVRI Per share dataNVRI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20

4.3 Compensation for Growth

NVRI's earnings are expected to grow with 85.86% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y63.71%
EPS Next 3Y85.86%

0

5. Dividend

5.1 Amount

NVRI does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

ENVIRI CORP

NYSE:NVRI (10/17/2025, 8:04:01 PM)

After market: 12.35 0 (0%)

12.35

-0.06 (-0.48%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryCommercial Services & Supplies
Earnings (Last)08-05 2025-08-05/bmo
Earnings (Next)11-10 2025-11-10/bmo
Inst Owners102.14%
Inst Owner ChangeN/A
Ins Owners3.52%
Ins Owner Change6.84%
Market Cap996.03M
Analysts77.78
Price Target15.13 (22.51%)
Short Float %11.02%
Short Ratio7.74
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-28.8%
Min EPS beat(2)-74.89%
Max EPS beat(2)17.28%
EPS beat(4)2
Avg EPS beat(4)-27.74%
Min EPS beat(4)-115.08%
Max EPS beat(4)61.74%
EPS beat(8)6
Avg EPS beat(8)87.76%
EPS beat(12)10
Avg EPS beat(12)106.02%
EPS beat(16)12
Avg EPS beat(16)93.4%
Revenue beat(2)0
Avg Revenue beat(2)-4.21%
Min Revenue beat(2)-4.4%
Max Revenue beat(2)-4.01%
Revenue beat(4)0
Avg Revenue beat(4)-5.54%
Min Revenue beat(4)-8.35%
Max Revenue beat(4)-4.01%
Revenue beat(8)3
Avg Revenue beat(8)-0.38%
Revenue beat(12)6
Avg Revenue beat(12)0.53%
Revenue beat(16)7
Avg Revenue beat(16)-4.27%
PT rev (1m)0%
PT rev (3m)3.49%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-147.61%
EPS NY rev (1m)0%
EPS NY rev (3m)-127.28%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-1.77%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.41%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 302.7
P/S 0.44
P/FCF N/A
P/OCF 15.03
P/B 2.65
P/tB N/A
EV/EBITDA 10.9
EPS(TTM)-0.45
EYN/A
EPS(NY)0.04
Fwd EY0.33%
FCF(TTM)-0.88
FCFYN/A
OCF(TTM)0.82
OCFY6.65%
SpS27.81
BVpS4.67
TBVpS-8.31
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -5.68%
ROE -41.84%
ROCE 1.95%
ROIC 1.53%
ROICexc 1.61%
ROICexgc 3.27%
OM 1.86%
PM (TTM) N/A
GM 18.36%
FCFM N/A
ROA(3y)-4.77%
ROA(5y)-3.06%
ROE(3y)-26.4%
ROE(5y)-16.72%
ROIC(3y)2.87%
ROIC(5y)2.63%
ROICexc(3y)3.01%
ROICexc(5y)2.75%
ROICexgc(3y)6.33%
ROICexgc(5y)5.89%
ROCE(3y)3.66%
ROCE(5y)3.35%
ROICexcg growth 3Y0.32%
ROICexcg growth 5Y-3.16%
ROICexc growth 3Y1.95%
ROICexc growth 5Y-1.33%
OM growth 3Y-11.02%
OM growth 5Y-12.23%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1%
GM growth 5Y-3.78%
F-Score2
Asset Turnover0.81
Health
Industry RankSector Rank
Debt/Equity 3.97
Debt/FCF N/A
Debt/EBITDA 6.76
Cap/Depr 76.88%
Cap/Sales 6.14%
Interest Coverage 250
Cash Conversion 30.01%
Profit Quality N/A
Current Ratio 1.19
Quick Ratio 0.88
Altman-Z 1.84
F-Score2
WACC8.69%
ROIC/WACC0.18
Cap/Depr(3y)80.65%
Cap/Depr(5y)82.53%
Cap/Sales(3y)6.35%
Cap/Sales(5y)7.1%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1400%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1200%
EPS Next Y-608.34%
EPS Next 2Y63.71%
EPS Next 3Y85.86%
EPS Next 5YN/A
Revenue 1Y (TTM)-0.92%
Revenue growth 3Y8.22%
Revenue growth 5Y14.23%
Sales Q2Q%-7.83%
Revenue Next Year-4.15%
Revenue Next 2Y-0.29%
Revenue Next 3Y0.92%
Revenue Next 5Y2.49%
EBIT growth 1Y-69.21%
EBIT growth 3Y-3.7%
EBIT growth 5Y0.27%
EBIT Next Year129.28%
EBIT Next 3Y5.84%
EBIT Next 5Y25.03%
FCF growth 1Y12.13%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y8.61%
OCF growth 3Y2.64%
OCF growth 5YN/A